Eurofarma’s Acquisition of 100% stake in Productos Farmacéuticos Medipharm


Claro & Cia. and DLA Piper Chile advised on the deal

Eurofarma, through Laboratorio Eurofarma Chile, executed the acquisition of 100% stake in Productos Farmacéuticos Medipharm from Inversiones SB.

Eurofarma Laboratórios S.A. produces and markets medical prescription, generic medication, veterinary, and oncology drugs. The company is based in São Paulo.

Based in Santiago, Productos Farmaceuticos Medipharm Ltda, engages in development of Pharmaceutical products.

Claro & Cia. advised Laboratorio Eurofarma Chile with Matías de Marchena (Picture), Vicente Allende and Trinidad Rojas.

DLA Piper advised Inversiones SB with José Pablo Dulanto, Manola Quiroz, Jorge Timmermann and María del Pilar Paredes.

Involved fees earner: Vicente Allende – Claro y Cia; Matías de Marchena – Claro y Cia; Trinidad Rojas – Claro y Cia; María del Pilar Paredes – DLA Chile; José Pablo Dulanto – DLA Chile; Manola Quiroz – DLA Chile; Jorge Timmermann – DLA Chile;

Law Firms: Claro y Cia; DLA Chile;

Clients: Empresas SB; Eurofarma Laboratórios S.A.;

Author: Ambrogio Visconti.